Elm Street Ventures
  • PORTFOLIO
  • STRATEGY
  • TEAM
  • NEWS
  • RESOURCES
  • CONTACT
Select Page

Elm Street Ventures backs Yale Spin-out Artizan BioSciences

Feb 6, 2017 | Portfolio Company News

Elm Street Ventures announced that it has invested in Artizan Biosciences, Inc. as part of a $5 million Series A financing round. The financing was led by Hatteras Venture Partners.

Recent Posts

  • Elm Street Ventures’ Portfolio Company Saphlux, Inc. Raises $5 Million in Additional Funding
  • P2 Science closes Series B financing; will build manufacturing plant in New Haven
  • Elm Street Ventures backs Yale Spin-out Artizan BioSciences

Archives

  • April 2017
  • March 2017
  • February 2017

Categories

  • Portfolio Company News

Designed by Elegant Themes | Powered by WordPress